EXE — Extendicare Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedMid CapHigh Flyer

Annual income statement for Extendicare, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.

	R2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	1,167	1,222	1,305	1,466	1,660
Cost of Revenue
Gross Profit	133	109	151	201	237
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	1,132	1,210	1,245	1,351	1,516
Operating Profit	34.7	11.9	60.3	115	144
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	14	-4.5	44.8	99.9	130
Provision for Income Taxes
Net Income After Taxes	7.5	-4.51	34	75.2	96.7
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	11.5	69.6	34	75.2	96.7
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	17.7	75.8	34	81.9	96.7
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.123	0.122	0.424	0.846	1.08
Dividends per Share